Caldwell Trust Co Acquires Shares of 4,620 Lam Research Corporation $LRCX

Caldwell Trust Co bought a new position in Lam Research Corporation (NASDAQ:LRCX) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 4,620 shares of the semiconductor company’s stock, valued at approximately $450,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. IMG Wealth Management Inc. acquired a new position in Lam Research in the second quarter worth $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research in the 2nd quarter worth about $27,000. Strategic Wealth Investment Group LLC acquired a new position in shares of Lam Research in the 2nd quarter valued at about $29,000. Delos Wealth Advisors LLC bought a new stake in shares of Lam Research during the 2nd quarter valued at about $30,000. Finally, REAP Financial Group LLC acquired a new stake in Lam Research during the second quarter worth about $31,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have commented on LRCX. Rothschild & Co Redburn lifted their target price on Lam Research from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. B. Riley raised their price target on Lam Research from $160.00 to $175.00 and gave the stock a “buy” rating in a report on Monday, October 20th. Citigroup boosted their price objective on Lam Research from $175.00 to $190.00 and gave the company a “buy” rating in a research report on Tuesday, November 11th. Morgan Stanley raised their target price on Lam Research from $137.00 to $158.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 2nd. Finally, Sanford C. Bernstein upped their price target on shares of Lam Research from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Friday, November 21st. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and a consensus price target of $157.54.

Insider Transactions at Lam Research

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares of the company’s stock, valued at $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 102,608 shares of company stock valued at $14,916,496 in the last quarter. Company insiders own 0.31% of the company’s stock.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $163.26 on Wednesday. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $169.69. The firm’s 50-day simple moving average is $153.29 and its 200 day simple moving average is $121.65. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The stock has a market cap of $205.06 billion, a P/E ratio of 35.96, a P/E/G ratio of 1.69 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. Lam Research’s quarterly revenue was up 27.7% on a year-over-year basis. During the same quarter last year, the company earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is presently 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.